• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Amendment: SEC Form SCHEDULE 13G/A filed by Medline Inc.

    5/7/26 6:40:43 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care
    Get the next $MDLN alert in real time by email



    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549


    SCHEDULE 13G


    UNDER THE SECURITIES EXCHANGE ACT OF 1934
    (Amendment No. 1)


    Medline Inc.

    (Name of Issuer)


    Class A Common Stock, par value $0.0001 per share

    (Title of Class of Securities)




    58507V107

    (CUSIP Number)
    03/31/2026

    (Date of Event Which Requires Filing of this Statement)


    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
    Checkbox not checked   Rule 13d-1(b)
    Checkbox not checked   Rule 13d-1(c)
    Checkbox checked   Rule 13d-1(d)




    schemaVersion:


    SCHEDULE 13G

    CUSIP Number(s):
    58507V107


    1Names of Reporting Persons

    Abu Dhabi Investment Authority
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED ARAB EMIRATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    517,241.00
    6Shared Voting Power

    40,838,099.00
    7Sole Dispositive Power

    517,241.00
    8Shared Dispositive Power

    40,838,099.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    41,355,340.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.9 %
    12Type of Reporting Person (See Instructions)

    OO

    Comment for Type of Reporting Person:  (1) Abu Dhabi Investment Authority is the direct owner of 517,241 of the shares of Class A Common Stock represented herein. (2) The percent calculation is based on 845,611,435 shares of Class A Common Stock outstanding as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on March 6, 2026, after giving effect to the full exercise of the underwriters' over-allotment option, as described therein.


    SCHEDULE 13G

    CUSIP Number(s):
    58507V107


    1Names of Reporting Persons

    Platinum Falcon B 2018 RSC Limited
    2Check the appropriate box if a member of a Group (see instructions)

    Checkbox not checked  (a)
    Checkbox not checked  (b)
    3Sec Use Only
    4Citizenship or Place of Organization

    UNITED ARAB EMIRATES
    Number of Shares Beneficially Owned by Each Reporting Person With:
    5Sole Voting Power

    0.00
    6Shared Voting Power

    40,838,099.00
    7Sole Dispositive Power

    0.00
    8Shared Dispositive Power

    40,838,099.00
    9Aggregate Amount Beneficially Owned by Each Reporting Person

    40,838,099.00
    10Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

    Checkbox not checked
    11Percent of class represented by amount in row (9)

    4.8 %
    12Type of Reporting Person (See Instructions)

    CO

    Comment for Type of Reporting Person:  (1) Platinum Falcon B 2018 RSC Limited ("Platinum Falcon") is the direct owner of 40,838,099 of the shares of Class A Common Stock reported herein. Platinum Falcon is a wholly owned subsidiary of Abu Dhabi Investment Authority. Pursuant to the rules and regulations of the Securities and Exchange Commission, Abu Dhabi Investment Authority may be deemed to be the beneficial owner of the shares of Class A Common Stock directly held by Platinum Falcon. (2) The percent calculation based on 845,611,435 shares of Class A Common Stock outstanding as reported in Medline Inc.'s prospectus filed pursuant to Rule 424(b)(4) with the Securities and Exchange Commission on March 6, 2026, after giving effect to the full exercise of the underwriters' over-allotment option, as described therein.


    SCHEDULE 13G

    Item 1. 
    (a)Name of issuer:

    Medline Inc.
    (b)Address of issuer's principal executive offices:

    3 Lakes Drive, Northfield, IL 60093
    Item 2. 
    (a)Name of person filing:

    This Schedule 13G/A is being filed on behalf of the following: 1. Abu Dhabi Investment Authority 2. Platinum Falcon B 2018 RSC Limited
    (b)Address or principal business office or, if none, residence:

    1. 211 Corniche Street P.O. Box 3600 Abu Dhabi, United Arab Emirates 3600 2. Level 26, Al Khatem Tower Abu Dhabi Global Market Square Al Maryah Island, Abu Dhabi United Arab Emirates
    (c)Citizenship:

    1. Abu Dhabi Investment Authority (ADIA) is a public institution established by the Government of the Emirate of Abu Dhabi in 1976 as an independent investment institution. 2. Platinum Falcon B 2018 RSC Limited is a restricted scope company organized under the laws of the Abu Dhabi Global Market, Abu Dhabi, United Arab Emirates.
    (d)Title of class of securities:

    Class A Common Stock, par value $0.0001 per share
    (e)CUSIP No.:

    58507V107
    Item 3.If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
    (a)Checkbox not checked   Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
    (b)Checkbox not checked   Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
    (c)Checkbox not checked   Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
    (d)Checkbox not checked   Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
    (e)Checkbox not checked   An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
    (f)Checkbox not checked   An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
    (g)Checkbox not checked   A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
    (h)Checkbox not checked   A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
    (i)Checkbox not checked   A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
    (j)Checkbox not checked   A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
           please specify the type of institution:
    (k)Checkbox not checked   Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
     
    Item 4.Ownership
    (a)Amount beneficially owned:

    See responses to Item 9 on each cover page.
    (b)Percent of class:

    See responses to Item 11 on each cover page.
    (c)Number of shares as to which the person has:
     (i) Sole power to vote or to direct the vote:

    See responses to Item 5 on each cover page.

     (ii) Shared power to vote or to direct the vote:

    See responses to Item 6 on each cover page.

     (iii) Sole power to dispose or to direct the disposition of:

    See responses to Item 7 on each cover page.

     (iv) Shared power to dispose or to direct the disposition of:

    See responses to Item 8 on each cover page.

    Item 5.Ownership of 5 Percent or Less of a Class.
     
    Checkbox checked    Ownership of 5 percent or less of a class
    Item 6.Ownership of more than 5 Percent on Behalf of Another Person.
     
    Not Applicable
    Item 7.Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
     
    Not Applicable
    Item 8.Identification and Classification of Members of the Group.
     
    Not Applicable
    Item 9.Notice of Dissolution of Group.
     
    Not Applicable

    Item 10.Certifications:
     
    Not Applicable

        SIGNATURE 
     
    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

     
    Abu Dhabi Investment Authority
     
    Signature:/s/ Saif Surour Omair Maaded AlMashghouni
    Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
    Date:05/07/2026
     
    Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
    Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
    Date:05/07/2026
     
    Platinum Falcon B 2018 RSC Limited
     
    Signature:/s/ Saif Surour Omair Maaded AlMashghouni
    Name/Title:Saif Surour Omair Maaded AlMashghouni/Authorized Signatory
    Date:05/07/2026
     
    Signature:/s/ Ahmed Salem Abdulla Melaih AlNeyadi
    Name/Title:Ahmed Salem Abdulla Melaih AlNeyadi/Authorized Signatory
    Date:05/07/2026
    Get the next $MDLN alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $MDLN

    DatePrice TargetRatingAnalyst
    3/11/2026$60.00Buy
    Citigroup
    2/5/2026$55.00Buy
    Tigress Financial
    1/21/2026$50.00 → $55.00Buy
    BTIG Research
    1/12/2026$48.00Buy
    Citigroup
    1/12/2026$38.00Neutral
    BNP Paribas Exane
    1/12/2026$50.00Overweight
    Analyst
    1/12/2026$50.00Overweight
    Piper Sandler
    1/12/2026$48.00Overweight
    Morgan Stanley
    More analyst ratings

    $MDLN
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Gic Private Ltd sold $289,480,090 worth of shares (10,204,351 units at $28.37) and bought $364,999,974 worth of shares (12,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 5:26:57 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Andrew J. was granted 30,655 units of Class B Common Stock and bought $74,999,974 worth of shares (2,586,206 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:06 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Mills Charles N. was granted 64,005 units of Class B Common Stock and bought $74,799,990 worth of shares (2,579,310 units at $29.00) (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    12/22/25 4:30:04 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Medline's Prime Vendor model expands outside the United States

    Agreement with Mohawk Medbuy in Canada marks first-of-its-kind Prime Vendor relationship outside the U.S.NORTHFIELD, Ill., May 29, 2026 /PRNewswire/ -- Medline (NASDAQ:MDLN) announced that Medline Canada has signed its first Prime Vendor agreement in the country and is the first Medline Prime Vendor relationship outside the United States. The agreement is with Mohawk Medbuy (MMC), one of Canada's largest healthcare procurement organizations, to support warehouse and supply chain logistics for its hospitals in Southwestern Ontario and builds from best practices from similar agreements with hundreds of healthcare providers in the U.S.

    5/29/26 10:25:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline Inc. announces closing of upsized secondary offering of Class A common stock

    NORTHFIELD, Ill., May 28, 2026 (GLOBE NEWSWIRE) -- Medline Inc. (NASDAQ:MDLN) ("Medline") announced today that it has closed its upsized secondary offering of 72,554,594 shares of Medline Inc.'s Class A common stock by certain selling stockholders affiliated with Blackstone Inc., Hellman & Friedman LLC and a wholly owned subsidiary of the Abu Dhabi Investment Authority (the "Selling Stockholders") at a price to the public of $37.00 per share. The Selling Stockholders have also granted the underwriters a 30-day option to purchase up to an additional 10,883,189 shares of Medline's Class A common stock. Medline did not sell any shares of Class A common stock in the offering and did not recei

    5/28/26 4:30:00 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline announces participation in upcoming investor conferences

    NORTHFIELD, Ill., May 27, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that members of the executive leadership team will be participating in the following investor conferences. Mike Drazin, chief financial officer, and Amanda Laabs, chief product officer, are scheduled to present at the William Blair 46th Annual Growth Stock Conference in Chicago, IL, on Wednesday, June 3, 2026, at 3:40pm ET.Jim Boyle, chief executive officer, and Mike Drazin, chief financial officer, are scheduled to present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami Beach, FL, on Tuesday, June 9, 2026, at 10:40am ET. Webcasts of the presentations will be a

    5/27/26 7:30:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Hellman & Friedman Capital Partners X (Parallel), L.P. sold $1,164,385,709 worth of shares (31,868,237 units at $36.54) and disposed of 1,887,801 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 6:16:21 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Director Healy Patrick J acquired 202,106 shares, increasing direct ownership by 15% to 1,387,921 units (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 6:05:43 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Large owner Bx Mozart Ml-2 Holdco L.P. sold $1,217,349,994 worth of shares (33,317,824 units at $36.54) and disposed of 438,214 shares (SEC Form 4)

    4 - Medline Inc. (0002046386) (Issuer)

    6/1/26 4:15:05 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    SEC Filings

    View All

    Medline Inc. filed SEC Form 8-K: Creation of a Direct Financial Obligation, Entry into a Material Definitive Agreement

    8-K - Medline Inc. (0002046386) (Filer)

    6/2/26 8:06:32 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form 424B4 filed by Medline Inc.

    424B4 - Medline Inc. (0002046386) (Filer)

    5/26/26 4:05:33 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    SEC Form EFFECT filed by Medline Inc.

    EFFECT - Medline Inc. (0002046386) (Filer)

    5/22/26 12:15:23 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Citigroup resumed coverage on Medline with a new price target

    Citigroup resumed coverage of Medline with a rating of Buy and set a new price target of $60.00

    3/11/26 8:38:58 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Tigress Financial initiated coverage on Medline with a new price target

    Tigress Financial initiated coverage of Medline with a rating of Buy and set a new price target of $55.00

    2/5/26 10:03:24 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    BTIG Research reiterated coverage on Medline with a new price target

    BTIG Research reiterated coverage of Medline with a rating of Buy and set a new price target of $55.00 from $50.00 previously

    1/21/26 1:17:48 PM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    $MDLN
    Financials

    Live finance-specific insights

    View All

    MediWound Reports First Quarter 2026 Financial Results and Provides Corporate Update

    EscharEx® Phase III VALUE trial advancing; interim assessment and enrollment completion expected by the end of the first quarter of 2027 First quarter revenue of $1.5 million; full-year 2026 revenue guidance reaffirmed at $24-26 million Conference Call Today, May 27, 2026, at 8:30 a.m. Eastern Time YAVNE, Israel, May 27, 2026 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ:MDWD), a global leader in next-generation enzymatic therapeutics for tissue repair, today announced financial results for the first quarter ended March 31, 2026, and provided a corporate update. "During the first quarter, we continued to advance both our strategic and operational priorities," said Ofer Gonen, Chief Execut

    5/27/26 7:00:00 AM ET
    $MDLN
    $MDWD
    Medical/Dental Instruments
    Health Care
    Medicinal Chemicals and Botanical Products

    Medline Reports First Quarter 2026 Results

    Net sales of $7.4 billion, an increase of 10.7%Net income of $239 million, a decrease of 25.8%Adjusted EBITDA1 of $776 million, a decrease of 10.6%Raising full year 2026 Organic Sales2 guidance range to 8.5% to 9.5% NORTHFIELD, Ill., May 06, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline" or the "Company") (NASDAQ:MDLN), the largest provider of medical-surgical ("med-surg") products and supply chain solutions serving all points of care3, today reported its operating results for the three months ended March 28, 2026. "We started 2026 with strong momentum—growing with our existing customers, executing implementations at scale and winning new customers," said Jim Boyle, chief executive off

    5/6/26 7:30:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care

    Medline to report first quarter 2026 results on May 6, 2026

    NORTHFIELD, Ill., April 08, 2026 (GLOBE NEWSWIRE) -- Medline Inc. ("Medline") (NASDAQ:MDLN) today announced that it plans to report first quarter 2026 financial results on Wednesday, May 6, 2026. A press release and supplemental materials will be issued before the market opens. The company will host a webcast and conference call at 9:30am ET/ 8:30am CT to discuss the financial results. Information about Medline's financial results, including a link to the live webcast, will be available on the Events page of Medline's Investor Relations website at ir.medline.com. A replay of the webcast will be available following the event through the same website. About MedlineMedline is the largest pr

    4/8/26 9:00:00 AM ET
    $MDLN
    Medical/Dental Instruments
    Health Care